Skip to main content
. 2021 Sep 23;10(10):1146. doi: 10.3390/antibiotics10101146

Table 2.

Causative agents of HAIs that underwent AST from 1 April 2019–31 March 2021.

Isolates n = 226 (%) BSI (n = 98) PN (n = 79) UTI (n = 19)
Acinetobacter spp. 85 (37.6) 26 (26.5) 57 (72.2) 2 (10.5)
Enterococcus spp. 28 (12.4) 11 (11.2) 2 (2.5) 8 (42.1)
Coagulase-negative Staphylococcus 27 (11.9) 26 (26.5)
Pseudomonas aeruginosa 21 (9.3) 3 (3.1) 11 (13.9) 2 (10.5)
Klebsiella spp. 21 (9.3) 7 (7.1) 5 (6.3) 5 (26.3)
Proteus mirabilis 8 (3.5) 1 (1.0) 1 (5.3)
Escherichia coli 5 (2.2) 1 (1.0) 1 (5.3)
Providencia spp. 5 (2.2) 2 (2.0)
Other Staphylococcal species 5 (2.2) 5 (5.1)
Staphylococcus aureus 4 (1.8) 2 (2.0) 2 (2.5)
Diphtheroids 4 (1.8) 3 (3.1) 1 (1.3)
Stenotrophomonas maltophilla 4 (1.8) 3 (3.1) 1 (1.3)
Corynebacterium spp. 3 (1.3) 3 (3.1)
Achromobacter xylooxidans 3 (1.3) 3 (3.1)
Prevotella spp. 1 (0.4) 1 (1.0)
Kocuria kristinae 1 (0.4) 1 (1.0)

n, number of isolates; BSI, bloodstream infection; PN, pneumonia; UTI, urinary tract infection.